Streetbeat News

Equity Actions

TPET

Trio Petroleum's stock is trading higher after the company announced borrowing $125,000 from its CEO, issuing an Unsecured Subordinated Promissory Note in the process.

Portfolio Pulse from Benzinga Newsdesk

April 02, 2024 | 12:20 pm

GRTS

Gritstone Bio announced a $32.5 million underwritten public offering of 8,333,333 shares of common stock and accompanying common warrants at $1.50 per share, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

April 02, 2024 | 12:16 pm

PTC

12 financial analysts have recently shared their evaluations of PTC (NASDAQ:PTC), showing a mix of bullish and bearish perspectives. The average 12-month price target is $199.92, indicating an 11.87% increase from the previous target. Analysts' actions include maintaining and raising ratings, with price targets ranging from $177.00 to $210.00. PTC's financial performance shows an 18.09% revenue growth rate, but it faces challenges with below-industry net margin, ROE, ROA, and a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

April 02, 2024 | 12:01 pm

TRMB

Analysts have varied opinions on Trimble (NASDAQ:TRMB), with recent ratings showing a shift towards a more bullish outlook. The average 12-month price target has risen to $65.38 from $56.00, indicating a 16.75% increase. Analyst actions include maintaining and raising ratings, with price targets adjusted accordingly. Trimble's financial performance is strong, with notable revenue growth, net margin, ROE, and ROA, although its debt-to-equity ratio suggests potential financial challenges.

Portfolio Pulse from Benzinga Insights

April 02, 2024 | 12:00 pm

GETY

Getty Images has filed for an offering of up to 1.2 million Class A common shares by the selling securityholder, as per the S-3 filing.

Portfolio Pulse from Charles Gross

April 02, 2024 | 11:41 am

CHX

SLB

Schlumberger (SLB) announced it will acquire ChampionX (CHX) in an all-stock transaction. The deal is expected to generate pre-tax synergies of approximately $400 million within three years. Following the acquisition, SLB aims to increase its total returns to shareholders to $3 billion in 2024 and sets a target of $4 billion for 2025.

Portfolio Pulse from Benzinga Newsdesk

April 02, 2024 | 11:32 am

ROIV

Roivant Sciences shares surged following the announcement of positive results from its NEPTUNE Phase 2 study of brepocitinib. Additionally, the company's board approved a share repurchase program of up to $1.5 billion, which includes buying back all 71.3 million shares owned by Sumitomo Pharma.

Portfolio Pulse from Benzinga Newsdesk

April 02, 2024 | 11:28 am

KSCP

Knightscope announced plans to significantly reduce its payroll expenses by over 30% in 2024 and consolidate its manufacturing operations from 13 facilities down to 1 to enhance process flow and efficiency. This strategic move aims to reduce real estate, inventory, and operating expenses.

Portfolio Pulse from Benzinga Newsdesk

April 02, 2024 | 11:14 am

ONTX

Onconova Therapeutics, Inc. (ONTX) has completed an all-stock acquisition of Trawsfynydd Therapeutics, Inc., with a combined equity value of $132M. Additionally, Trawsfynydd will raise $14M through committed private placement financing.

Portfolio Pulse from Benzinga Newsdesk

April 02, 2024 | 11:13 am

ROIV

Roivant Sciences announced a board authorization for a share repurchase program up to $1.5B, including buying back the entire stake of Sumitomo Pharma for $648M, reducing shares outstanding by 9%.

Portfolio Pulse from Benzinga Newsdesk

April 02, 2024 | 11:12 am